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Abstract 
Background: The purpose of this study was evaluation of the antimicrobial effect of ethyl acetate extract and 
alkaloid fraction of Glaucium vitellinum (G. vitellinum) against clinical Staphylococcus spp. isolates from 
patients of Sina hospital of Tehran. 
Materials and Methods: The plant of G. vitellinum was collected from Khonsar, Isfahan province, during May 
2014. It’s flowering and aerial parts were washed, dried, powdered and extracted with methanol and ethyl 
acetate by using percolator apparatus, separately. In continuation, the alkaloid fraction was separated from 
metanolic total extract. 100 clinical isolates of Staphylococcus spp. were collected randomly from different 
clinical samples of patients who referred to Sina hospital of Tehran during 2013-2014. Also, their resistant to 
common antibiotics were evaluated by disk diffusion method based on the CLSI 2014 protocol. Continuously, 
the antibacterial effect of ethyl acetate total extract and the alkaloid fraction against clinical isolates of 
Staphylococcus spp. were evaluated by determining the minimal inhibitory concentration (MIC) by 
microdilution method based on the CLSI 2014. Standard Staphylococcus aureus (PTCC1431) and 
Staphylococcus epidermidis (PTCC 1435) were evaluated, simultaneously. 
Results: Based on the results, 93% of isolates were coagulase positive and 7% were coagulase negative 
Staphylococci spp. (CoNS). All coagulase positive cocci were identified as Staphylococcus aureus and 
among 7% CoNS, 3% were identified as S. epidermidis, so, in the follow they are named only CoNS.  
The MIC of alkaloid fraction of G.vitellinum was: 17.87 mg/ml and 23.21 mg/ml against coagulase positive 
S.aureus and CoNS isolates, respectively. Also, MIC of ethyl acetate total extract of G.vitellinum was: 73.25 
mg/ml and 98.21mg/ml on coagulase positive S. aureus and CoNS isolates, respectively. 
61.29% of clinical S. aureus isolates were sensitive to ethyl acetate total extract  and 100 % were sensitive to 
alkaloid fraction while 100% were penicillin resistant while only 60%  of them were 
Trimethoprim/sulfamethoxazole (SXT) sensitive. 
Similarly, among CoNS isolates, 42.85% and 100% were sensitive to ethyl acetate total extract and alkaloid 
fraction, respectively. While 100% were penicillin resistant and only 42%were ciprofloxacin and 
doxycycline sensitivity. 
Conclusion: based on the existence of good antibacterial effect for alkaloid portion of G. vitellinum against 
clinical isolates of Staphylococcus spp. doing other in vitro and in vivo complementation tests are 
recommended for the further studies. 
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Introduction 
In the recent decades emerge of antibiotic resistant 
pathogens has been a worldwide problem. Also the 
undesirable some side effects of the antibiotics, urge 
researchers to search for new sources to combat these 
problems1. 
Staphylococcus spp. are gram positive, non-motile, 
oxidase-negative, urease positive and fermentative 
cocci2,3. Staphylococcus aureus can cause scaling 
skin syndrome (SSS), food toxication, toxic shock, 
impetigo and welding endocarditis. The other species 
Staphylococcus epidermidis can cause endocarditis, 
infection of the central nervous system, catheter-
related bacteremia and wound infection4,5. 
On the other hand, Iran is a good place of growing 
medicinal herbs or plants and there are a lot of 
documents about their usage as an alternative 
treatment. The potential of traditional herbal 
medicines cannot be underestimated before any 
examination. Antibacterial properties have been 
reported to be found in the wide range of medicinal 
plants6. 
Glaucium vitellinum (G. vitellinum) is a hairy, 
biannual plant which is a member of Papaverasea 
family7. G. vitellinum, is a local plant of Khonsar, a 
city of Isfahan province of Iran, and has many 
confirmed properties such as pain killer, anti-
inflammation, diaphoretic, sedative and insomnia 
treatment7-9.  
Based on some studies, some of the alkaloids 
derivates of Glaucium spp showed anti-microbial 
effect10,11.  
Based on our previous study, the alkaloid fraction of 
G.vitellinum was effective against standard strains of 
Staphylococcus aureus (PTCC 1431), Klebsiella 
pneumonia (PTCC1053), Salmonella typhi 
(PTCC1639), Escherichia coli (PTCC1399) and 
Pseudomonas aeruginosa (PTCC1430)12. 
So, the purpose of this study was evaluation of the 
antibacterial effect of ethylacetate extract and alkaloid 
fraction of G. vitellinum against clinical 
Staphylococcus spp isolates from patients of Sina 
hospital of Tehran. 
Methods 
Extraction preparation: The plant was collected 
from Khonsar (a city of Isfahan province, Iran) during 
May 2014. It’s flowering and aerial parts were 
washed, dried, powdered and extracted by methanol 
and ethyl acetate, separately. Then both extracts were 
gathered, filtered and dried for three hours using 
percolator apparatus. The alkaloid fraction was 
separated from methanolic extract, continuously12. 
Bacterial strains: Different clinical samples including 
blood, urine and body discharges were collected from 
patients of Sina hospital of Tehran during 2013-14. All 
samples were cultured on the proper media based on 
standard microbial protocols for staphylococcus 
isolation13. All used media such as blood agar, 
Mannitol salt agar, and Mueller Hinton agar were 
purchased from Merck Co, Germany. 
Consequently, Gram staining, urease test, catalase, 
oxidase, and coagulase tests were used to confirm the 
Staphylococcus identification13. Then 100 
Staphylococcus spp. were collected randomly. Also, 
species differentiation was done by culturing on 
Mannitol salt agar, coagulase test and susceptibility to 
novobiocin disk (Padtan Teb Co, Iran)13. 
Their resistant to common antibiotics (All antibiotic 
disks were purchased from Mast Co, Uk) were 
determined in the next step by disk diffusion method 
based on CLSI 2014 protocol14. 
Consequently, the antibacterial effect of ethyl acetate 
total extract and the alkaloid fraction was evaluated by 
determining the minimum inhibitory concentration 
(MIC) against 100 clinical staphylococcus spp. 
isolates by the microdilution method based on the 
CLSI 2014. Further Minimum bacteriocidal 
concentration (MBC) was determined after culture. 
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Staphylococcus aureus (PTCC1431) and 
Staphylococcus epidermidis (PTCC1435) were 
evaluated, simultaneously.  
Based on our preliminary study, 125 mg of the dried 
ethyl acetate extract was weighted and dissolved in 1 
ml of 4%DMSO. Also, 100 mg of the alkaloid dried 
extract was weighted and dissolved in one ml of 4% 
DMSO12. Serial dilution was prepared from each 
extract and using 100μl of Mueller Hinton broth. 
Bacterial suspension was made equal to turbidity of 
0.5 McFarland standard and immediately before 
adding to wells diluted 20 times (1:20).Total volume 
of each well was 200μl (each well was contained 
100μl of each extract dilution, 90μl of Mueller 
Hinton broth and 10μl of diluted bacterial 
suspension). The microplates were incubated at 37°C 
for 24 hours. The MIC and MBC were reported 
based on last turbidity and growth on Mueller-Hinton 
agar, respectively. 
Test accreditation: to accredit the results, all 
concentrations of total extract and DMSO were 
cultured in wells to identify their presumptive 
microbial infection. Also, methicillin and DMSO 4% 
were used as positive and negative control, 
respectively. 
Statistical analysis: the results were analyzed by 
STAT software and calculation the multiple T-test. 
Results 
Frequencies of clinical samples were as follow; 49% 
blood, 40% body fluids, 7% trachea and 4% wound. 
Based on the bacterial tests in this experimental 
study, all Staphylococcus spp. were gram positive 
cocci, catalase positive, oxidaze negative, resistant to 
bacitracin disk (0.04U) with positive growth on 
mannitol salt agar.  All isolates with positive 
mannitol fermentation and positive tube coagulase test 
identified as S. aureus. For all urease positive and 
coagulase negative isolates, novobiocin disk 
susceptibility test was used to differentiate S. 
epidermidis from S. saprophyticus.  
So, 93% of isolates were coagulase positive S.aureus 
and 7% were coagulase negative (CoNS; 3% 
S.epidermidis, 1% S. saprophyticus and 2% other 
species), While the antibacterial effect of ethylacetat 
and the alkaloid fraction against staphylococcus 
isolates was the main aim of this study, it was  
mentioned only to S. aureus coagulase positive  and 
CoNS isolates in the following of the paper.  
The MIC of alkaloid fraction of G.vitellinum was: 
17.87mg/ml and 23.21mg/ml against S. aureus and 
CoNS isolates, respectively (p value<0.0001). The 
MIC of standard S.aureus (PTCC1431) and S. 
epidermidis (PTCC1435) was 1.5625mg/ml and 
0.75mg/ml, respectively (table1, p value <0.0001). 
Also, the MIC of ethylacetate total extract of 
G.vitellinum was: 73.25 mg/ml and 98.21 mg/ml 
against S. aureus and CoNS isolates, respectively 
(table2).The MIC against S.aureus (PTCC 1431) and 
S. epidermidis (PTCC 1435) was 78.10 mg/ml and 
62.5mg/ml (Table 2, P value <0.0001). 
Also, the MBC of ethylacetate total extract of G. 
vitellinum were: 116.3mg/ml and196 mg/ml on S. 
aureus and CoNS isolates, respectively. The MBC 
were 156 mg/ml and 130.25 mg/ml against standard S. 
aureus (PTCC 1431) and S. epidermidis (PTCC 1435) 
(Table 3, P value <0.0001).  
The MBC of alkaloid fraction of G. vitellinum were: 
35.41mg/ml and 45.83mg/ml against S. aureus, S. 
epidermidis and CoNS isolates, respectively. The 
MBC were 3.125mg/ml and 1.5 mg/ml against 
standard S. aureus (PTCC 1431) and S.epidermidis 
(PTCC 1435) (Table 4, P value<0.0001). 
Table 1: The MIC (mg/ml) of alkaloid extract of G.vitellinum. 
 Alkaloid Fraction DMSO Methicillin T test P value 




CoNS isolates 5.103±23.21 <0.0001 
Standard S. aureus 
(PTCC1431) 0.0±1.5625 <0.0001 
Standard S. epidermidis 
(PTCC 1435) 0.0±0.75 <0.0001 
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So, 61.29% of clinical S. aureus isolates were 
sensitive to ethyl acetate total extract and 100% were 
sensitive to alkaloid fraction while 100% were 
penicillin resistant in the antimicrobial sensitivity 
test. 
Similarly, among CoNS isolates, 42.85% and 100% 
were sensitive to ethyl acetate total extract and 
alkaloid fraction, respectively. While 100% were 
penicillin resistant in the antimicrobial sensitivity 
test. 
Discussion 
Based on our literature review, there is no any study 
on the antibacterial effect of G. vitellinum except our 
previous study. The only other existed studies are 
related to Cabo et al. and Semnani et al., who worked 
on different species of Glaucium other than 
vitellinum10,11.   
Based on the results of Cabo et al. in 1988, the root 
extract of the Glaucium flavum, showed the 
antibacterial effect against gram-positive bacteria10. 
However Semnani et al. in 2005, showed that extracts 
of 3 other species of Glaucium (including: G. 
grandiflorum, G. oxylobum and G. paucibolum) have 
antimicrobial activity against Gram-negative 
bacteria11. 
In our previous study, the crude extract and alkaloid 
sub-fraction of G. vitellinum had significant inhibition 
activity on the growth of standard S. aureus   as a 
gram positive bacteria and S. typhi as a gram negative 
bacteria13.   
So existence of good antibacterial effect of G. 
vitellinum in our previous study encouraged us to 
survey this effect against clinical isolates of 
Staphylococcus spp. collected from Sina hospital of 
Tehran in the recent study for the first time.  
However, the species of Glacium in the Cabo et al. and 
Semnani et al. studies were different, but all the results 
in addition to our previous and recent studies were 
strongly confirmed the antimicrobial effect of this 
Table 2: MIC (mg/ml) of ethylacetate total extract of G.vitellinum. 
 Total ethyl acetate extract DMSO Methicillin T test P value 




CoNS isolates 34.23±98.21 0.17 
Standard S. aureus 
(PTCC1431) 0.0±78.10 0.0001< 
Standard S. epidermidis 
(PTCC 1435) 0.0±62.5 <0.0001 
 
 Table 3: The MBC (mg/ml) of ethylacetate total extract of G.vitellinum. 
 Total ethyl acetate 
extract DMSO Methicillin T test P value 




CoNS isolates 0.0±196.0 0.0001< 
Standard S. aureus 
(PTCC1431) 0.0±156.0 0.0001< 
Standard S. epidermidis 
(PTCC 1435) 0.0±130.25 0.0001< 
 
 
Table 4: The MBC (mg/ml) of alkaloid fraction of G.vitellinum. 
 Alkaloid fraction DMSO Methicillin T test P value 




CoNS isolates 10.21±45.83 0.0001< 
Standard S. aureus 
(PTCC1431) 0.0±3.125 0.0001< 
Standard S. epidermidis 
(PTCC 1435) 0.0±1.5 0.0001< 
 
 
NBM                                                                            124                                   Novelty in Biomedicine 2016, 3, 121-5 
Study on Antibacterial Activity of Ethylacetate Total Extract and the Alkaloid Fraction from …                        Omrani et al.   
genus of the Iranian medicinal plant. 
Conclusion 
Based on the satisfy results of alkaloid fraction of G. 
vitellinum, identification of alkaloid ingredients and 
evaluation their antibacterial effect in the further 
studies are recommended.  
Also, doing other in vitro tests such as cytotoxicity 
and mutagenicity and in vivo studies of alkaloid 
fraction in the future is recommended for the 
substitution of G. vitellinum alkaloid fraction to 
common antibiotics as an alternative treatment. 
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